Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 35, 886-889, April 1, 1975]
© 1975 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marks, D. B.
Right arrow Articles by Marks, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marks, D. B.
Right arrow Articles by Marks, A. D.

The Presence of Histone H1° in Human Tissues1

Dawn B. Marks, Terry Kanefsky2, Barbara J. Keller and Allan D. Marks

Departments of Biochemistry [D. B. M., T. K., and B. J. K.] and Medicine [A. D. M.] Temple University School of Medicine, Philadelphia, Pennsylvania 19140

Histone H1° was found to be present in a number of human tissues. It constituted 50% of the total 5% perchloric acid-soluble histone in human breast, 35% in thyroid, 12 to 18% in adrenal, and 7% in parathyroid tissues. The quantities of histone H1° in these human tissues were large compared with the amounts found in rat liver (8%), calf thymus (0%), and HeLa cells (0%).

Although the quantity of histone H1° was found to vary from one type of tissue to another, it was essentially constant in normal, hyperplastic, and neoplastic human thyroid tissues.

1 This work was supported by USPHS Grant GM 18843 and Institutional Grant IN88E to Temple University from the American Cancer Society.

2 Present address: Presbyterian-University Hospital, Pittsburgh, Pa.

Received 9/17/74. Accepted 12/19/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1975 by the American Association for Cancer Research.